XECHEM INTERNATIONAL INC
NT 10-K, 1999-03-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOCORAL INC, NT 10-K, 1999-03-31
Next: QUINTILES TRANSNATIONAL CORP, 10-K, 1999-03-31



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                           NOTIFICATION OF LATE FILING

                                   FORM 12b-25

SEC File Number  0-23788                 Cusip Number  983895
               ----------------------                -----------------------

                                   [Check One]
     |X| Form 10-K  |_| Form 20-F |_| Form 11-K  |_| Form 10-Q  |_| Form N-SAR

                  For the Period Ended:       December 31, 1998

                  [   ] Transition Report on Form 10-K
                  [   ] Transition Report on Form 20-F
                  [   ] Transition Report on Form 11-K
                  [   ] Transition Report on Form 10-Q
                  [   ] Transition Report on Form N-SAR

                  For the Transition Period Ended___________________

             Read Instructions [on back page] Before Preparing Form.
                              Please Print or Type

           Nothing in this form shall be constructed to imply that the
                Commission has verified any information contained
                                     herein

         If the notification relates to a portion of the filing checked
              above, identify the Item[s] to which the notification
                                    relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant:XECHEM INTERNATIONAL, INC.

Former Name if Applicable:
Address of Principal Executive Office [Street and Number]:100 JERSEY AVENUE B310

City, State and Zip Code: NEW BRUNSWICK, NEW JERSEY 08901

PART II - RULES 12b-25[b] and [c]

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25[b], the following should
be completed.

                           [Check box if appropriate]

      [a] The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expenses;

[X]   [b] The subject annual report,  semi-annual report,  transition report
          on Form 10-K,  Form 2-F, Form 11-K,  Form N-SAR,  or portion thereof ,
          will be filed on or before the  fifteenth  calendar day  following the
          prescribed  due date;  or the subject  quarterly  report or transition
          report on Form 10-Q, or portion thereof will be filed on or before the
          fifth calendar day following the prescribed due date; and

      [c] The accountant's statement or other exhibit required by Rule 12b-25[c]
          has been attached if applicable.


<PAGE>



PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q
or N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.

The  Company  has  not  yet  received  audited  financial  statements  from  its
independent accountants.

PART IV - OTHER INFORMATION

    [1]  Name and telephone number of person to contact in regard to this
         notification

                Ramesh C. Pandey                   732             247-3300
                   [Name]                      [Area Code]      [Telephone No.]

    [2] Have all other  periodic  reports  required under Section 13 or 15[d] of
        the  Securities and Exchange Act of 1934 or Section 30 of the Investment
        Company Act of 1940 during the  preceding 12 months [or for such shorter
        period  that the  registrant  was  required to file such  reports]  been
        filed? If answer is no, identify report[s]. [X ] Yes [ ] No



    [3] Is it anticipated  that any significant  change in results of operations
        from the corresponding period for the last fiscal year will be reflected
        by the  earnings  statements  to be included  in the  subject  report or
        portion thereof? [X ] Yes [ ] No

        If so, attach an explanation of the anticipated change, both narratively
        and  quantitatively,  and,  if  appropriate,  state  the  reasons  why a
        reasonable estimate of the results cannot be made.

        Since audited financial  statements are still in the preliminary stages,
        the Company is not yet able to determine  whether such  statements  will
        reflect any significant change in results of operations.



                             XECHEM INTERNATIONAL, INC.
                  [Name of Registrant as Specified in Charter]

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.

Date        March 30, 1999            By /s/ Ramesh C. Pandey
    -----------------------------       ----------------------
                                         Ramesh C. Pandey
                                         President/Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
[other than an executive officer], evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
                                    ATTENTION
           Intentional misstatements or omissions of fact constitute
                Federal Criminal Violation  [See 18 U.S.C. 1001]

                              GENERAL INSTRUCTIONS

1.  This form is  required  by Rule  12b-25 [17 CFR  240.12b-25]  of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed  original and four  conformed  copies of this form and amendments
    thereto  must be  completed  and  filed  with the  Securities  and  Exchange
    Commission,  Washington,  D.C.  20549,  in  accordance  with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in or
    filed  with  the form  will be made a matter  of the  public  record  in the
    Commission files.

3.  A manually  signed copy of the form and  amendments  thereto  shall be filed
    with each national  securities  exchange on which any class of securities of
    the registrant is registered.

4   Amendments to the notifications  must also be filed on form 12b-25, but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amendment notification.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission